Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunological Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00048685
What this trial is testing

Study of Oral Bacteria in Patients With Dry Mouth

Who this might be right for
XerostomiaAutoimmune Diseases
National Institute of Dental and Craniofacial Research (NIDCR) 44
Early research (Phase 1)Not Yet RecruitingNCT07306585
What this trial is testing

The Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HC022 Injection in Subjects With SLE/CLE

Who this might be right for
Systemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)
HC Biopharma Inc. 32
Testing effectiveness (Phase 2)Study completedNCT02927964
What this trial is testing

TLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular Lymphoma

Who this might be right for
Grade 1 Follicular LymphomaGrade 2 Follicular LymphomaGrade 3a Follicular Lymphoma+4 more
Robert Lowsky 21
Not applicableUnknownNCT06167564
What this trial is testing

Allergy Diagnostic Test Based on Microchip Technology

Who this might be right for
AllergyAllergy;FoodAllergy Pollen+1 more
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus 400
Testing effectiveness (Phase 2)Study completedNCT04660799
What this trial is testing

A Study on Pharmacokinetics (PK), Efficacy and Safety of Subcutaneous (SC) Versus Intravenous (IV) Rituximab, in Combination With CHOP (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone) in Previously Untreated Participants With CD20 Positive Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Hoffmann-La Roche 50
Not applicableStudy completedNCT03602599
What this trial is testing

Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy Controls

Who this might be right for
Graft Versus Host Disease
National Institute of Dental and Craniofacial Research (NIDCR) 190
Early research (Phase 1)Study completedNCT02203799
What this trial is testing

Peanut Oral Immunotherapy in Children With Peanut Allergy (Peanut Flour)

Who this might be right for
Peanut Allergic Subjects
Baylor College of Medicine 15
Early research (Phase 1)Study completedNCT06535399
What this trial is testing

Study to Assess Drug Levels and Safety of Golcadomide (BMS-986369) in Healthy Participants and Participants With Different Degrees of Hepatic Impairment

Who this might be right for
Hepatic ImpairmentHealthy Volunteers
Celgene 29
Early research (Phase 1)Ended earlyNCT06163898
What this trial is testing

Evaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 4
Large-scale testing (Phase 3)Study completedNCT00117598
What this trial is testing

Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)

Who this might be right for
Lymphoma
Pfizer 169
Not applicableLooking for participantsNCT07270263
What this trial is testing

Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies

Who this might be right for
LymphomaLeukemiaMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma+4 more
Medical University of Gdansk 100
Large-scale testing (Phase 3)Study completedNCT01561521
What this trial is testing

An Evaluation of the Onset and Duration of Action of AKF-1 Ophthalmic Solution in Treating Acute Allergic Conjunctivitis

Who this might be right for
Allergic Conjunctivitis
Akorn, Inc. 90
Not applicableUnknownNCT03490084
What this trial is testing

Impacts on Health Outcomes and Resources Utilization of Hospital-at-home for Elderly Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Assistance Publique - Hôpitaux de Paris 300
Not applicableStudy completedNCT02598752
What this trial is testing

Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeHematological Malignancy+3 more
Memorial Sloan Kettering Cancer Center 11
Testing effectiveness (Phase 2)Study completedNCT00076752
What this trial is testing

Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
National Cancer Institute (NCI) 9
Not applicableActive Not RecruitingNCT06323447
What this trial is testing

Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia

Who this might be right for
Diffuse Large B Cell LymphomaMultiple Myeloma
Leuko Labs, Inc. 210
Testing effectiveness (Phase 2)Study completedNCT00654147
What this trial is testing

Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects

Who this might be right for
HIV Infections
Margaret A. Fischl, M.D. 44
Testing effectiveness (Phase 2)Ended earlyNCT03943147
What this trial is testing

An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis

Who this might be right for
Lupus Nephritis
Bristol-Myers Squibb 16
Large-scale testing (Phase 3)Study completedNCT02294058
What this trial is testing

Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis
Celgene 1,346
Testing effectiveness (Phase 2)UnknownNCT02047578
What this trial is testing

Targeted Busulfan, Fludarabine, Etoposide Conditioning Regimen for HSCT in Childhood and Adolescent ALL.

Who this might be right for
Acute Lymphoblastic Leukemia
Seoul National University Hospital 38
Next Page